Association for Voluntary Surgical Contraception: a technical statement on quinacrine pellets for nonsurgical female sterilization.
For many years, researchers have been seeking nonsurgical methods for female sterilization because these methods may be safer, simpler, cheaper, and quicker than conventional techniques, and may require a lower level of skill to deliver. Various investigators have explored using intrauterine instillation of quinacrine for tubal occlusion. Until recently, reports of quinacrine use for nonsurgical sterilization have been scarce and limited to data sets involving small numbers with very short-term follow-up. The July 24, 1993 issue of the Lancet reports on 31,781 cases of nonsurgical sterilization with quinacrine in a field trial from Vietnam. The present paper is written as a background review to assist family planning providers in the dialogue regarding the introduction and use of quinacrine. It attempts to answer questions regarding what is currently known about the safety and efficacy of quinacrine, and what the recent article published in the Lancet adds to our knowledge. It also raises the question of how quinacrine sterilization affects free and informed choice and the other interests of family planning clients.
Pollack
A E
AE
Association for Voluntary Surgical Contraception, New York, NY 10016.
Carignan
C S
CS
D005260:Female; D006801:Humans; D011247:Pregnancy; D011796:Quinacrine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D013246:Sterilization, Tubal / Q000379:methods*; D014599:Uterus; D014744:Vietnam
D011796:Quinacrine